作者在这项研究中,给34例晚期宫颈癌患者于第1天静注表柔比星100mg/m~2、紫杉醇175mg/m~2和顺铂100mg/m~2,21天1个疗程。大多数患者接受2个疗程的治疗,8个人接受3个疗程的治疗。中位随访期为17个月,总计33例有效(78.5%),其中8例完全有效。32例进行切除术,组织病理学检查显示8例令人满意(25%),中位无病生存期48个月。5例复发病人中,仅1例有满意疗 In this study, 34 patients with advanced cervical cancer were treated with epirubicin 100 mg / m ~ 2, paclitaxel 175 mg / m ~ 2, and cisplatin 100 mg / m ~ 2,21 for 1 course on day 1 . Most patients receive 2 courses of treatment and 8 persons receive 3 courses of treatment. The median follow-up period was 17 months, a total of 33 cases were effective (78.5%), of which 8 were completely effective. Thirty-two resections were performed. Histopathologic examination showed satisfactory results (25%) in 8 patients and a median disease-free survival of 48 months. Of the 5 patients who relapsed, only 1 patient had satisfactory treatment